TABLE 4.
Change values, Nm |
||
Treatment | Baseline to 6 wk | Baseline to 12 wk |
Isometric KE | ||
PB | 13 (−9, 36) | 32 (9, 55) |
WP | 29 (5, 52) | 36 (11, 60) |
MDP | 9 (−15, 33) | 29 (4, 53) |
Isometric KF | ||
PB | 13 (2, 25) | 12 (1, 24) |
WP | 5 (−7, 17) | 11 (−1, 24) |
MDP | 2 (−11, 14) | 13 (−1, 25) |
Isokinetic KE | ||
PB | 4 (−9, 18) | 17 (3, 31)a,b |
WP | 15 (1, 29) | 19 (4, 34)a |
MDP | 5 (−9, 20) | 4 (−11, 19)b |
Isokinetic KF | ||
PB | 7 (−5, 19) | 6 (−6, 19) |
WP | 3 (−9, 16) | 13 (−1, 26) |
MDP | 1 (−11, 14) | 3 (−10, 17) |
Values are means (95% CIs). Sample sizes/group at baseline, 6 wk, and 12 wk, respectively—MDP: n = 23, 19, and 18; PB: n = 23, 23, and 21; and WP: n = 21, 20, and 18. Labeled means (at that time point) without a common superscript letter differ, P < 0.05. KE, knee extension; KF, knee flexion; MDP, maltodextrin placebo; Nm, Newton meters; PB, soy-dairy protein blend; WP, whey protein.